These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35070563)

  • 41. The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness.
    Yamamoto M; Yasunaga H; Kakinoki R; Tsubokawa N; Morita A; Tanaka K; Sakai A; Kurahashi T; Hirata H;
    Sci Rep; 2022 May; 12(1):9094. PubMed ID: 35641603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes and Direct Costs of Needle Aponeurotomy, Collagenase Injection, and Fasciectomy in the Treatment of Dupuytren Contracture.
    Leafblad ND; Wagner E; Wanderman NR; Anderson GR; Visscher SL; Maradit Kremers H; Larson DR; Rizzo M
    J Hand Surg Am; 2019 Nov; 44(11):919-927. PubMed ID: 31537401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of a Handprint for Clinical Evaluation of Dupuytren's Contracture.
    Ajiki T; Murayama A; Hayashi Y; Takeshita K
    J Hand Microsurg; 2023 Jun; 15(3):181-187. PubMed ID: 37388561
    [No Abstract]   [Full Text] [Related]  

  • 44. Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.
    Strömberg J; Ibsen Sörensen A; Fridén J
    J Bone Joint Surg Am; 2018 Jul; 100(13):1079-1086. PubMed ID: 29975270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budget impact analysis in Spanish patients with Dupuytren's contracture: fasciectomy vs. collagenase Clostridium histolyticum.
    De Salas-Cansado M; Cuadros M; Del Cerro M; Arandes JM
    Chir Main; 2013 Apr; 32(2):68-73. PubMed ID: 23507313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
    Kaplan FT
    Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease.
    McMahon HA; Bachoura A; Jacoby SM; Zelouf DS; Culp RW; Osterman AL
    Hand (N Y); 2013 Sep; 8(3):261-6. PubMed ID: 24426932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Overview of Dupuytren's Disease for Perioperative Nurses.
    Russell MC
    AORN J; 2022 Jan; 115(1):65-78. PubMed ID: 34958472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of Dupuytren's contracture by collagenase injection].
    Foissac R; Camuzard O; Dumas P; Dumontier C; Chignon-Sicard B
    Chir Main; 2013 Sep; 32(4):199-205. PubMed ID: 23856551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dupuytren's Contracture: An Evidence Based Review.
    Mella JR; Guo L; Hung V
    Ann Plast Surg; 2018 Dec; 81(6S Suppl 1):S97-S101. PubMed ID: 30161050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complications after treating Dupuytren's disease. A systematic literature review.
    Krefter C; Marks M; Hensler S; Herren DB; Calcagni M
    Hand Surg Rehabil; 2017 Oct; 36(5):322-329. PubMed ID: 28917432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphological patterns of the pretendinous cord in Dupuytren's disease: a predictor of clinical outcome?
    Vanek P; Strömberg J; Fridén J; Aurell Y
    J Plast Surg Hand Surg; 2018 Aug; 52(4):240-244. PubMed ID: 29741424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early results of the use of collagenase in the treatment of Dupuytren's contracture.
    Considine S; Heaney R; Hirpara KM
    Ir J Med Sci; 2015 Jun; 184(2):323-7. PubMed ID: 24705775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of Dupuytren's disease with collagenase - a 1-year follow-up of 37 patients].
    Binter A; Neuwirth M; Rab M
    Handchir Mikrochir Plast Chir; 2014 Dec; 46(6):355-60. PubMed ID: 25564949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.
    Witthaut J; Bushmakin AG; Gerber RA; Cappelleri JC; Le Graverand-Gastineau MP
    Clin Drug Investig; 2011 Nov; 31(11):791-8. PubMed ID: 21967070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique.
    Verheyden JR
    J Hand Surg Eur Vol; 2015 Feb; 40(2):133-40. PubMed ID: 24698852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors predicting the 1-year outcome of collagenase treatment for Dupuytren's disease.
    Scheibler AG; Marks M; Hensler S; Herren DB; Calcagni M
    Arch Orthop Trauma Surg; 2019 Apr; 139(4):583-588. PubMed ID: 30673868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.